News

16th September, 2016The formation of lung granuloma is the pathological hallmark of pulmonary Tuberculosis disease resulting from the direct struggle between the immune system and Mycobacterium tuberculosis.

14th September, 2016Sensitisation is the first step in the immune response leading to allergy. House dust mites (HDM) possess allergens that are internalised and expressed by antigen presenting cells in the airways.

12th September, 2016Targeting IL-4 receptor alpha mediated signalling: A new therapeutic strategy for fibroproliferative diseases? Schistosomiasis is a parasitic disease caused by infective helminthes of the trematoda class. It is

September 9th, 2016 Broadly neutralising antibodies (bnAbs) against HIV have been one of the the main focuses in the design an effective HIV vaccine. However, since the Thai RV144 HIV vaccine trial, attention has been

August 1st, 2016 AIDS 2016 was a meeting of the world’s foremost HIV/AIDS researchers in both the social and biological sciences. The conference, whose theme was “Accessing Equity Rights Now,” focused on the needs of “key populations.”

August 4th, 2016 Chlamydia is one of the most common sexually transmitted diseases with nearly 113 million infections per year, however many cases are left asymptomatic. When left untreated, chlamydia often leads to serious health outcomes including pelvic inflammatory disease and tubal factor infertility. In the 25 July edition of Vaccine, researchers from McMaster University may have discovered the first protective vaccine against chlamydia...

July 27th, 2016 The 21st International AIDS Conference came to a close this past Friday with over 18 000 delegates attending from around the world. The conference included panel discussions, poster presentations, exhibitions,

July 21st, 2016 Today, July 21 2016, the International AIDS Conference held in Durban, South Africa convened the fourth day of its conference. One session of note was known as "Treatment Evolution: New Drugs, New Reality." Speakers included Drs Jean-Michel Molina, Dr. Alejandro Arenas-Pinto, Dr. Michael Aboud, Dr. Deanna Kerrigan, Dr. Catherine Orell, and Dr. David Margolis. The talk focused on how AIDS treatment regimens needed to be adapted as new drugs have been released...

July 22nd, 2016 In 2014, UNAIDS rolled out the ambitious 90-90-90 target for 2020 in which "90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy and 90% of all people receiving antiretroviral therapy will have viral suppression". But how economically feasible is this goal?

July 19th, 2016 The 21st International Conference kicked off yesterday in Durban, South Africa with nearly 20 000 delegates attending from across the globe. On Tuesday July 19th, the conference held a vaccine symposium that addressed the latest research and progress on HIV vaccines and antibody prophalixis trials in southern Africa. The session was led by medical virologist at the University of Cape Town, Wendy Anne Burgers, and...